Private industry now funds more of India's R&D than the government
Private industry funded 51.8% of India's R&D spending in 2023-24 for the first time, and total R&D crossed 0.83% of GDP in 2021-22 — the highest since 2009-10 — according to the Department of Science and Technology's Research and Development Statistics 2025-26.
What happened
The Department of Science and Technology's (DST) Research and Development Statistics 2025-26 shows that India's R&D spending reached 0.83% of GDP in 2021-22, the first time it crossed 0.8% since 2009-10, and is estimated to approach 0.9% of GDP in 2025-26. Private industry's share of national R&D spending rose from 45.5% in 2021-22 to 51.8% in 2023-24 — the first time businesses outspent all levels of government combined. Transportation companies were the single largest industrial R&D investors at ₹39,137 crore in 2023-24, followed by drugs and pharmaceuticals (₹25,847 crore), biotechnology (₹10,321 crore), information technology (₹9,587 crore) and electrical and electronics (₹6,779 crore).
Context
The previous DST statistical compendium, released in 2020 with data up to 2018-19, had transport R&D at only around ₹14,000 crore and biotechnology and IT at much smaller shares. Since then, transport-sector R&D has almost tripled, biotech has emerged as one of India's largest research-intensive industries, and IT has entered the top corporate R&D spenders. The DST attributes the surge to a post-Covid 'realisation' by firms that R&D is critical to their future, and to stricter RBI disclosure requirements on R&D spends. Data comes from self-reported industry questionnaires, with methodology unchanged from prior editions.
Why it matters
The level of R&D spending matters — 0.83% of GDP in 2021-22 is the first time India crossed 0.8% since 2009-10, and 0.9% is now within reach — but the composition matters more. When government funds most of the R&D, output tilts toward defence, atomic energy and space programmes; when business enterprises take the lead, activity tilts toward commercialisable innovation in pharma, biotech and mobility. The workforce shift — private industry now employing more full-time-equivalent researchers than government institutions — signals a durable rerouting of scientific talent into the private sector, changing where the returns to public spending on higher education ultimately land.
Impact for India
- Innovation-intensive sectors: transportation, pharmaceuticals, biotech and IT get identified as the corporate R&D engines, strengthening their case for targeted R&D-linked tax incentives and skilling schemes.
- MSMEs and mid-tier firms: 90% of the reported R&D spend came from just around 500 companies out of nearly 8,000 in the DST database, flagging a very thin R&D base outside the top layer.
- Scientific and Industrial Research Organisations (SIROs) and private universities: contributed ₹7,798 crore and ₹9,164 crore respectively of the ₹1.27 lakh crore private R&D pool in 2023-24, still small relative to business enterprises' ₹1.11 lakh crore.
- Public research institutions: their falling share does not necessarily mean falling spending, but it does change India's basic-research pipeline calculus.
- Policy and regulation: with RBI disclosure requirements already citing as a driver, more granular corporate reporting norms and R&D-linked incentives become more effective policy levers.
Key data
Concepts
Stakeholders
Practice Question — from the story
With reference to the Department of Science and Technology's Research and Development Statistics 2025-26, consider the following statements:
- Drugs and pharmaceuticals was the single largest industrial R&D contributor in 2023-24, ahead of the transportation sector.
- Private industry's share of national R&D spending fell below the government's share for the first time in 2023-24.
Which of the statements given above is/are correct?
Reveal answer & explanation
Answer: Neither 1 nor 2
- Statement 1: Incorrect. Transportation was the single largest industrial R&D contributor at ₹39,137 crore; drugs and pharmaceuticals ranked second at ₹25,847 crore.
- Statement 2: Incorrect. Private industry's share rose to 51.8% in 2023-24 — the first time businesses contributed more to R&D than all levels of government combined.
Therefore, the correct answer is Neither 1 nor 2.
Concept check — test your understanding
Two industries have very different R&D-to-sales ratios: biotechnology reports a high double-digit share of its turnover spent on R&D, while transportation reports a much smaller share even though transport firms spend the largest absolute rupee amount on R&D. What does this contrast most directly illustrate?
Reveal answer & explanation
Answer: D
- R&D intensity is spending scaled by sales, so a sector with modest turnover but heavy research needs — like biotech — can show a very high ratio, while a large-turnover sector like transport can spend the biggest absolute rupee amount and still have a relatively small ratio.
- A misreads the ratio as a universal ranking of 'innovation'; the article itself flags absolute spend and R&D intensity as separate measures.
- B introduces a subsidy-flow claim not supported by the report and confuses the direction of causation.
- C reverses the arithmetic — if biotech had larger revenues, its R&D-to-sales ratio would fall, not rise.